NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
Yang Liu
M D Anderson Cancer Center University of Texas - Houston / United States
Others
AD Scientific Index ID: 1422030
MD Anderson Cancer Center
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Yang Liu's MOST POPULAR ARTICLES
1-)
Thiadiazole—A promising structure in medicinal chemistryY Li, J Geng, Y Liu, S Yu, G ZhaoChemMedChem 8 (1), 27-41, 20132202013
2-)
Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphomaL Zhang, Y Yao, S Zhang, Y Liu, H Guo, M Ahmed, T Bell, H Zhang, G Han, ...Science translational medicine 11 (491), eaau1167, 20191312019
3-)
Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistryWH Guo, X Qi, X Yu, Y Liu, CI Chung, F Bai, X Lin, D Lu, L Wang, J Chen, ...Nature communications 11 (1), 1-16, 2020752020
4-)
Recent advances in the development of thioredoxin reductase inhibitors as anticancer agentsY Liu, Y Li, S Yu, G ZhaoCurrent drug targets 13 (11), 1432-1444, 2012822012
5-)
Ibrutinib with rituximab in first-line treatment of older patients with mantle cell lymphomaP Jain, S Zhao, HJ Lee, HA Hill, CY Ok, R Kanagal-Shamanna, ...Journal of Clinical Oncology 40 (2), 202-212, 2022652022
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept